Abivax SA <ABVX.O>: Truist Securities cuts target price to $151 from $155
ABVX•Related News
MediWound Awarded Additional $3.3 Million From U.S. Department Of War To Advance Room-Temperature-Stable Formulation Of Nexobrid
MDWD•
Kazia says Sovargen doses first patient in Phase 1b/2a paxalisib trial for rare seizure disorders, triggers $2 million payment
KZIA•
DoorDash settles New York City delivery worker pay probe for $131.5 million
DASH•
Cyera Announces $400 Million Investment From Goldman Sachs To Build The Trust Layer For The Agentic Enterprise
GS•
Celldex's skin disease drug meets goals in two late-stage trials
CLDX•